Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Apr 26, 2023; 11(12): 2684-2693
Published online Apr 26, 2023. doi: 10.12998/wjcc.v11.i12.2684
Figure 1
Figure 1 Participant distribution in this study. POI: Premature ovarian insufficiency.
Figure 2
Figure 2 Comparison of anti-Müllerian hormone, antral follicle count, mean plasma levels of diacron-reactive oxygen metabolites, mean plasma levels of biological antioxidant potential, and the mean oxidase stress index between the control and premature ovarian insufficiency groups. A: Anti-Müllerian hormone; B: Antral follicle count; C: Mean plasma levels of diacron-reactive oxygen metabolites; D: Mean plasma levels of biological antioxidant potential; E: Mean oxidase stress index. Values are expressed as means, with the error bar representing the standard deviation. Significant difference between the control and premature ovarian insufficiency groups, P < 0.001. POI: Premature ovarian insufficiency; Cont: Control; AMH: Anti-Müllerian hormone; d-ROMs: Diacron-reactive oxygen metabolites; BAP: Biological antioxidant potential; OSI: Oxidase stress index.